SCHEMBL4254819

SCHEMBL4254819

CCCOC(C)(C)CNc1nc(-n2cnc3c(=O)[nH]c(=S)n(CC(C)(C)OCCC)c32)[nH]c1C(N)=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1777507 0.66 XDH (0.51) —
SCHEMBL1775036 0.61 ADORA2A (0.50) —
SCHEMBL1776355 0.53 XDH (0.47) —
SCHEMBL8905863 0.53 PNP (0.51) —
SCHEMBL14819849 0.49 ALDH1A1 (0.42) —
SCHEMBL10421280 0.48 PNP (0.79) —
SCHEMBL10775468 0.48 PNP (0.56) —
SCHEMBL12786352 0.48 PNP (0.60) —
SCHEMBL6268785 0.47 PNP (0.55) —
SCHEMBL8445570 0.47 PNP (0.76) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2029598-A1 2-THIOXANTHINE DERIVATIVES ACTING AS MPO-INHIBITORS Astra Zeneca AB (SE) 2009-03-04 — — EP disclosed
WO-2007142576-A1 2-THIOXANTHINE DERIVATIVES ACTING AS MPO-INHIBITORS ASTRAZENECA AB (SE) 2007-12-13 — — WO disclosed
Send feedback